An announcement from Keros Therapeutics ( (KROS) ) is now available.
Keros Therapeutics, a leader in developing novel therapeutics linked to the TGF-ß family of proteins, is set to present at the Guggenheim Healthcare Innovation Conference. The company’s CEO, Jasbir Seehra, will discuss their innovative treatments for various disorders including myelodysplastic syndrome, pulmonary arterial hypertension, and obesity. Investors can access a live audio webcast and replay on Keros’ website.
Learn more about KROS stock on TipRanks’ Stock Analysis page.
